Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population

Table 3 Hematological comparison between non-alcoholic fatty liver disease and controls among four groups

	Lean-NAFLD		Overweight-obese-NAFLD		P value
	Controls	NAFLD	Controls	NAFLD
WBC (109/L)	5.73 ± 1.46	6.40 ± 1.44a	6.25 ± 1.58b	6.72 ± 1.66ac	< 0.01
NEUT (109/L)	3.28 ± 1.12	3.70 ± 1.04a	3.62 ± 1.19b	3.88 ± 1.25ac	< 0.01
LYMPH (109/L)	1.96 ± 0.52	2.14 ± 0.56a	2.10 ± 0.57b	2.26 ± 0.60ac	< 0.01
MONO (109/L)	0.36 ± 0.14	0.39 ± 0.13a	0.39 ± 0.16b	0.42 ± 0.15a	< 0.01
EO (109/L)	0.09 ± 0.09	0.13 ± 0.14a	0.11 ± 0.10	0.14 ± 0.13a	< 0.01
BASO (109/L)	0.01 ± 0.04	0.01 ± 0.03	0.01 ± 0.03	0.02 ± 0.03	0.22
RBC (1012/L)	4.50 ± 0.41	4.76 ± 0.42a	4.72 ± 0.48b	4.96 ± 0.44ac	< 0.01
HGB (g/L)	136.13 ± 15.24	145.87 ± 16.44a	143.30 ± 17.05b	152.19 ± 14.22ac	< 0.01
HCT (%)	41.36 ± 4.11	44.09 ± 4.41a	43.40 ± 4.55b	45.68 ± 3.90ac	< 0.01

^aP < 0.05 vs control in same weight group;

^bP < 0.05 vs Lean-control group;

^cP < 0.05 vs Lean-NAFLD group. NAFLD: Non-alcoholic fatty liver disease; WBC: White blood cell count; NEUT: Neutrophils count; LYMPH: Lymphocytes count; MONO: Monocytes count; EO: Eosinophils count; BASO: Basophils count; RBC: Red blood cell count; HGB: Hemoglobin; HCT: Hematocrit value.